Literature DB >> 20977429

Biochemical and structural characterization of mouse mitochondrial aspartate aminotransferase, a newly identified kynurenine aminotransferase-IV.

Qian Han1, Howard Robinson, Tao Cai, Danilo A Tagle, Jianyong Li.   

Abstract

Mammalian mAspAT (mitochondrial aspartate aminotransferase) is recently reported to have KAT (kynurenine aminotransferase) activity and plays a role in the biosynthesis of KYNA (kynurenic acid) in rat, mouse and human brains. This study concerns the biochemical and structural characterization of mouse mAspAT. In this study, mouse mAspAT cDNA was amplified from mouse brain first stand cDNA and its recombinant protein was expressed in an Escherichia coli expression system. Sixteen oxo acids were tested for the co-substrate specificity of mouse mAspAT and 14 of them were shown to be capable of serving as co-substrates for the enzyme. Structural analysis of mAspAT by macromolecular crystallography revealed that the cofactor-binding residues of mAspAT are similar to those of other KATs. The substrate-binding residues of mAspAT are slightly different from those of other KATs. Our results provide a biochemical and structural basis towards understanding the overall physiological role of mAspAT in vivo and insight into controlling the levels of endogenous KYNA through modulation of the enzyme in the mouse brain.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 20977429      PMCID: PMC3046307          DOI: 10.1042/BSR20100117

Source DB:  PubMed          Journal:  Biosci Rep        ISSN: 0144-8463            Impact factor:   3.840


  67 in total

1.  wARP: improvement and extension of crystallographic phases by weighted averaging of multiple-refined dummy atomic models.

Authors:  A Perrakis; T K Sixma; K S Wilson; V S Lamzin
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  1997-07-01

2.  Energy metabolism in glutamatergic neurons, GABAergic neurons and astrocytes in primary cultures.

Authors:  L Hertz; J Drejer; A Schousboe
Journal:  Neurochem Res       Date:  1988-07       Impact factor: 3.996

3.  Plasma membrane fatty acid-binding protein and mitochondrial glutamic-oxaloacetic transaminase of rat liver are related.

Authors:  P D Berk; H Wada; Y Horio; B J Potter; D Sorrentino; S L Zhou; L M Isola; D Stump; C L Kiang; S Thung
Journal:  Proc Natl Acad Sci U S A       Date:  1990-05       Impact factor: 11.205

Review 4.  Endogenous kynurenines as targets for drug discovery and development.

Authors:  Trevor W Stone; L Gail Darlington
Journal:  Nat Rev Drug Discov       Date:  2002-08       Impact factor: 84.694

5.  An iontophoretic investigation of the actions of convulsant kynurenines and their interaction with the endogenous excitant quinolinic acid.

Authors:  M N Perkins; T W Stone
Journal:  Brain Res       Date:  1982-09-09       Impact factor: 3.252

6.  The brain metabolite kynurenic acid inhibits alpha7 nicotinic receptor activity and increases non-alpha7 nicotinic receptor expression: physiopathological implications.

Authors:  C Hilmas; E F Pereira; M Alkondon; A Rassoulpour; R Schwarcz; E X Albuquerque
Journal:  J Neurosci       Date:  2001-10-01       Impact factor: 6.167

7.  pH dependence, substrate specificity and inhibition of human kynurenine aminotransferase I.

Authors:  Qian Han; Junsuo Li; Jianyong Li
Journal:  Eur J Biochem       Date:  2004-12

8.  Kynurenic acid antagonises responses to NMDA via an action at the strychnine-insensitive glycine receptor.

Authors:  P J Birch; C J Grossman; A G Hayes
Journal:  Eur J Pharmacol       Date:  1988-09-01       Impact factor: 4.432

9.  Kynurenic acid blocks nicotinic synaptic transmission to hippocampal interneurons in young rats.

Authors:  Trevor W Stone
Journal:  Eur J Neurosci       Date:  2007-04-25       Impact factor: 3.386

10.  Biochemical and structural properties of mouse kynurenine aminotransferase III.

Authors:  Qian Han; Howard Robinson; Tao Cai; Danilo A Tagle; Jianyong Li
Journal:  Mol Cell Biol       Date:  2008-11-24       Impact factor: 4.272

View more
  11 in total

1.  Bi-allelic GOT2 Mutations Cause a Treatable Malate-Aspartate Shuttle-Related Encephalopathy.

Authors:  Clara D M van Karnebeek; Rúben J Ramos; Xiao-Yan Wen; Maja Tarailo-Graovac; Joseph G Gleeson; Cristina Skrypnyk; Koroboshka Brand-Arzamendi; Farhad Karbassi; Mahmoud Y Issa; Robin van der Lee; Britt I Drögemöller; Janet Koster; Justine Rousseau; Philippe M Campeau; Youdong Wang; Feng Cao; Meng Li; Jos Ruiter; Jolita Ciapaite; Leo A J Kluijtmans; Michel A A P Willemsen; Judith J Jans; Colin J Ross; Liesbeth T Wintjes; Richard J Rodenburg; Marleen C D G Huigen; Zhengping Jia; Hans R Waterham; Wyeth W Wasserman; Ronald J A Wanders; Nanda M Verhoeven-Duif; Maha S Zaki; Ron A Wevers
Journal:  Am J Hum Genet       Date:  2019-08-15       Impact factor: 11.025

2.  SIRT3-dependent GOT2 acetylation status affects the malate-aspartate NADH shuttle activity and pancreatic tumor growth.

Authors:  Hui Yang; Lisha Zhou; Qian Shi; Yuzheng Zhao; Huaipeng Lin; Mengli Zhang; Shimin Zhao; Yi Yang; Zhi-Qiang Ling; Kun-Liang Guan; Yue Xiong; Dan Ye
Journal:  EMBO J       Date:  2015-03-09       Impact factor: 11.598

3.  Kynurenine aminotransferase III and glutamine transaminase L are identical enzymes that have cysteine S-conjugate β-lyase activity and can transaminate L-selenomethionine.

Authors:  John T Pinto; Boris F Krasnikov; Steven Alcutt; Melanie E Jones; Thambi Dorai; Maria T Villar; Antonio Artigues; Jianyong Li; Arthur J L Cooper
Journal:  J Biol Chem       Date:  2014-09-17       Impact factor: 5.157

4.  Biochemical identification and crystal structure of kynurenine formamidase from Drosophila melanogaster.

Authors:  Qian Han; Howard Robinson; Jianyong Li
Journal:  Biochem J       Date:  2012-09-01       Impact factor: 3.857

5.  PRSS37 deficiency leads to impaired energy metabolism in testis and sperm revealed by DIA-based quantitative proteomic analysis.

Authors:  Wenfeng Xiong; Haoyang Ge; Chunling Shen; Chaojie Li; Xiaohong Zhang; Lingyun Tang; Yan Shen; Shunyuan Lu; Hongxin Zhang; Zhugang Wang
Journal:  Reprod Sci       Date:  2022-04-26       Impact factor: 3.060

6.  Regulation of brain glutamate metabolism by nitric oxide and S-nitrosylation.

Authors:  Karthik Raju; Paschalis-Thomas Doulias; Perry Evans; Elizabeth N Krizman; Joshua G Jackson; Oksana Horyn; Yevgeny Daikhin; Ilana Nissim; Marc Yudkoff; Itzhak Nissim; Kim A Sharp; Michael B Robinson; Harry Ischiropoulos
Journal:  Sci Signal       Date:  2015-07-07       Impact factor: 8.192

Review 7.  Abnormal kynurenine pathway of tryptophan catabolism in cardiovascular diseases.

Authors:  Ping Song; Tharmarajan Ramprasath; Huan Wang; Ming-Hui Zou
Journal:  Cell Mol Life Sci       Date:  2017-03-17       Impact factor: 9.261

Review 8.  Pyridoxal 5'-Phosphate-Dependent Enzymes at the Crossroads of Host-Microbe Tryptophan Metabolism.

Authors:  Barbara Cellini; Teresa Zelante; Mirco Dindo; Marina M Bellet; Giorgia Renga; Luigina Romani; Claudio Costantini
Journal:  Int J Mol Sci       Date:  2020-08-13       Impact factor: 5.923

9.  NQO1 protects obese mice through improvements in glucose and lipid metabolism.

Authors:  Andrea Di Francesco; Youngshim Choi; Michel Bernier; Yingchun Zhang; Alberto Diaz-Ruiz; Miguel A Aon; Krystle Kalafut; Margaux R Ehrlich; Kelsey Murt; Ahmed Ali; Kevin J Pearson; Sophie Levan; Joshua D Preston; Alejandro Martin-Montalvo; Jennifer L Martindale; Kotb Abdelmohsen; Cole R Michel; Diana M Willmes; Christine Henke; Placido Navas; Jose Manuel Villalba; David Siegel; Myriam Gorospe; Kristofer Fritz; Shyam Biswal; David Ross; Rafael de Cabo
Journal:  NPJ Aging Mech Dis       Date:  2020-11-19

Review 10.  Kynurenine Aminotransferase Isozyme Inhibitors: A Review.

Authors:  Alireza Nematollahi; Guanchen Sun; Gayan S Jayawickrama; W Bret Church
Journal:  Int J Mol Sci       Date:  2016-06-15       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.